Innovative MedTech Appoints Dr. Merle Griff as President of its Newly Acquired SarahCare Subsidiaries
SarahCare Founder to Continue Its Mission to Provide Supportive Adult Day Care Under Innovative MedTech Umbrella BLUE ISLAND, IL /...
News
CLS Holdings USA, Inc. Reports Record March Financial Results As Nevada Tourism Begins Recovery
LAS VEGAS, NV / ACCESSWIRE / April 13, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
Radiko Announces LVV Shareholders’ Decision to Cease Operations and Proceed With Winding-Up
LOS ANGELES, CA / ACCESSWIRE / April 13, 2021 / Radiko Holdings (CSE:RDKO) (the "Company") announced today that La Vida...
Ovation Science Provides Update on Topical Cannabis Research and Development Initiatives
VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / April 13, 2021 / Ovation Science Inc. (CSE:OVAT)(OTCQB:OVATF)("Ovation" or the "Company"), a topical...
Sparta Secures Exclusive Distribution Agreement with International Workplace Health and Building Monitoring Software Firm, Metrikus
TORONTO, ON / ACCESSWIRE / April 13, 2021 / Sparta Group (TSX.V:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital",...
NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference
FT. MYERS, FL / ACCESSWIRE / April 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global...
XIL Health Rebrands with Expanded Offerings, Bringing 32+ Years of Experience and Pioneering Technologies to Empower Innovative Healthcare Startups
As one of the nation’s leading strategic pharmacy economics experts, XIL Health provides actionable insights to encourage organizations, including retail...
SEngine Precision Medicine Presents Data at 2021 AACR Annual Meeting Demonstrating Clinical Utility and Predictive Value of PARIS® Test in Ovarian Cancer
SEATTLE, April 13, 2021 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company that pre-tests drugs on patient-derived live tumor...
Dimensions Health Centres Announces Company Formation, Closes Oversubscribed Initial Funding Round
TORONTO, April 13, 2021 (GLOBE NEWSWIRE) -- Dimensions Health Centres (“Dimensions”), a psychedelic treatment company, officially announced the company formation...
GeneThera’s Strategy for the Development of a Global Zoonotic Diseases Surveillance System Using Smart Testing Technology
WESTMINSTER, Colo., April 13, 2021 (GLOBE NEWSWIRE) -- We are developing the infrastructure of a global zoonotic infectious diseases “alert...
Resonant Customers Ship Record 8.6 Million RF Filters Leveraging ISN® Design Technology in First Quarter of 2021; Representing Year Over Year Growth of 437%
Resonant’s Intellectual Property Portfolio Increases to Over 320 Patents Issued and PendingAUSTIN, Texas., April 13, 2021 (GLOBE NEWSWIRE) -- Resonant...
Akouos Receives Orphan Drug and Rare Pediatric Disease Designations for AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss
BOSTON, April 13, 2021 (GLOBE NEWSWIRE) -- Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential...
CV Sciences and Alkemist Labs Form Partnership to Support the National Institute of Standards and Technology’s Cannabis Quality Assurance Program
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”),...
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting
EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies...
Albireo Expands Leadership with Joan Connolly as Chief Technology Officer
– Appointment strengthens leadership team as the Company readies for potential global odevixibat launch and progresses multiple clinical development programs...
Spark Therapeutics Enters Collaboration with Senti Bio to Bolster Industry-Leading Gene Therapy Research Platform
Collaboration combines Senti Bio’s leading-edge gene circuit technology platform and high-throughput synthetic promoter design capabilities with Spark Therapeutics’ investigational gene...
AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for Grade 1 Immune Checkpoint Inhibitor-Associated Colitis
Phase 1b/2a Study Expected to Begin In 2Q 2021DELRAY BEACH, Fla., April 13, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc....
Senti Bio Enters Collaboration with Spark Therapeutics to Develop Next-Generation Precision Gene Therapies
- Collaboration combines Senti Bio’s leading-edge gene circuit technology platform and high-throughput synthetic promoter design capabilities with Spark Therapeutics’ investigational...
Artelo Biosciences Reports Second Quarter Fiscal 2021 Financial Results and Provides Business Update
Recently Commenced Patient Enrollment in Phase 1/2 CAReS Study of ART27.13 in the UK Reported Positive Pre-Clinical Data Associated with...
INDUSTRY SOURCE CONSULTING TO APPOINT NEW MANAGEMENT IN THE COMING WEEKS
Thomasville, GA, April 13, 2021 (GLOBE NEWSWIRE) -- Industry Source Consulting, Inc. (OTC: INSO), is pleased to announce that the...